Bisphosphonates as a therapeutic choice for multifocal epithelioid hemangioma of bone: A case report

Conclusions: EH of multiple bones responded favorably to intravenous Zometa with improvement of bone metabolic markers. After 1 year on follow-up, the patient was doing well with no significant pain. We suggest that bisphosphonates should be considered in the treatment of multifocal osteolytic EH of bone.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Clinical Case Report Source Type: research